Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen G Mainz

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Archivos De Bronconeumologia|November 7, 2017
Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508delJochen G Mainz, Christin Arnold, Julia Hentschel, et al.
Expert Review of Respiratory Medicine|January 22, 2017
Adherence to therapies in cystic fibrosis: a targeted literature reviewSiva Narayanan, Jochen G Mainz, Smeet Gala, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 13, 2013
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutationHelge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer, et al.
Expert Review of Respiratory Medicine|July 19, 2022
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosisAnton Barucha, Renan M Mauch, Franziska Duckstein, et al.
Respiration; International Review of Thoracic Diseases|February 28, 2009
Substantially reduced calcaneal bone ultrasound parameters in severe untreated asthmaJochen G Mainz, Werner A Kaiser, James F Beck, et al.
Plos One|November 16, 2013
Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markersRuth K Michl, Julia Hentschel, Christiane Fischer, et al.
Expert Review of Respiratory Medicine|September 23, 2016
Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disordersRuth K Michl, Harold Tabori, Julia Hentschel, et al.
Pediatric Pulmonology|April 7, 2018
Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonizationAnke Jaudszus, Christin Arnold, Julia Hentschel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2012
Soluble inflammation markers in nasal lavage from CF patients and healthy controlsNatalie Beiersdorf, Matthias Schien, Julia Hentschel, et al.
Frontiers in Pharmacology|July 6, 2023
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapyPatience N Eschenhagen, Petra Bacher, Claudia Grehn, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Archivos De Bronconeumologia|November 7, 2017
Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508delJochen G Mainz, Christin Arnold, Julia Hentschel, et al.
Expert Review of Respiratory Medicine|January 22, 2017
Adherence to therapies in cystic fibrosis: a targeted literature reviewSiva Narayanan, Jochen G Mainz, Smeet Gala, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 13, 2013
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutationHelge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer, et al.
Expert Review of Respiratory Medicine|July 19, 2022
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosisAnton Barucha, Renan M Mauch, Franziska Duckstein, et al.
Respiration; International Review of Thoracic Diseases|February 28, 2009
Substantially reduced calcaneal bone ultrasound parameters in severe untreated asthmaJochen G Mainz, Werner A Kaiser, James F Beck, et al.
Plos One|November 16, 2013
Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markersRuth K Michl, Julia Hentschel, Christiane Fischer, et al.
Expert Review of Respiratory Medicine|September 23, 2016
Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disordersRuth K Michl, Harold Tabori, Julia Hentschel, et al.
Pediatric Pulmonology|April 7, 2018
Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonizationAnke Jaudszus, Christin Arnold, Julia Hentschel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2012
Soluble inflammation markers in nasal lavage from CF patients and healthy controlsNatalie Beiersdorf, Matthias Schien, Julia Hentschel, et al.
Frontiers in Pharmacology|July 6, 2023
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapyPatience N Eschenhagen, Petra Bacher, Claudia Grehn, et al.
Pageof 8